ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,625.30
      -0.15%
      US Tech 100
      20,083.60
      -0.17%
      Dow Jones
      39,856.96
      0.34%
      Brent Oil
      84.645
      -0.48%
      Bitcoin
      58,273.62
      0.89%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Fletcher King Plc (FLK) Quote

      Fletcher King Plc

      Fletcher King Plc (FLK)

      LSE
      46.00
      0.00
      ( 0.00% )
      Updated: 03:00:08
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      46.00
      Bid
      42.00
      Ask
      50.00
      Volume
      0.00
      46.00 Day's Range 46.00
      33.00 52 Week Range 48.00
      Market Cap
      4.716M
      Previous Close
      46.00
      Open
      46.00
      Last Trade
      (O)
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      14,318
      Shares Outstanding
      10,252,209
      Dividend Yield
      1.63%
      PE Ratio
      20.26
      Earnings Per Share (EPS)
      0.02
      Revenue
      3.13M
      Net Profit
      233k

      About Fletcher King Plc

      Sector
      Business Consulting Svcs,nec
      Industry
      Business Consulting Svcs,nec
      Website
      www.fletcherking.co.uk
      Headquarters
      London, Gbr
      Founded
      1970
      Fletcher King Plc is listed in the Business Consulting Svcs sector of the London Stock Exchange with ticker FLK. The last closing price for Fletcher King was 46p. Over the last year, Fletcher King shares have traded in a share price range of 33.00p to 48.00p.

      Fletcher King currently has 10,252,209 shares outstanding. The market capitalization of Fletcher King is £4.72 million. Fletcher King has a price to earnings ratio (PE ratio) of 20.26.

      FLK Latest News

      More News

      FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing

      2 hours ago

      Fletcher King PLC Holding(s) in Company

      Fletcher King PLC 06 June 2024     TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

      June 06 2024
      RNS Regulatory News

      TRADING UPDATES: Braveheart writes down value of two investments

      The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by ...

      May 17 2024
      Alliance News

      Fletcher King PLC Further re: Trading Update

      Fletcher King PLC 15 May 2024   For immediate release 15 May 2024   Fletcher King plc   ("Fletcher King" or the "Company")     Further re: Trading Update   In response to shareholder...

      May 15 2024
      RNS Regulatory News

      TRADING UPDATES: Fletcher King sees materially higher full-year sales

      The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Al ...

      May 03 2024
      Alliance News

      Fletcher King PLC Trading Update and Notice of Results

      Fletcher King PLC 03 May 2024   For immediate release 3 May 2024   Fletcher King plc   ("Fletcher King" or the "Company")     Trading Update Notice of Results     Fletcher King plc (AIM: FLK...

      May 03 2024
      RNS Regulatory News

      Fletcher King PLC Grant of Share Options

      Fletcher King PLC 19 March 2024   19 March 2024     Fletcher King plc               ("Fletcher King" or "the Company")     Grant of Share Options     The Board of Fletcher King PLC (AIM: FLK...

      March 19 2024
      RNS Regulatory News

      IN BRIEF: Fletcher King interim profit up mildly as outlook optimistic

      - London-based chartered surveyors firm - Pretax profit rises to GBP50,000 in the six months to October 31, from GBP3 ...

      December 21 2023
      Alliance News

      Fletcher King PLC Half-year Report

      Fletcher King PLC 21 December 2023 FLETCHER KING PLC ("Flecther King" or the "Company") Interim Results for the 6 months ended 31 October 2023 Financial Highlights Turnover:...

      December 21 2023
      UK Regulatory

      Fletcher King PLC Result of AGM

      Fletcher King PLC 11 October 2023 Fletcher King plc ("Fletcher King" or "the Company") Result of Annual General Meeting The Board of Fletcher King plc announces that, at the...

      October 11 2023
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      112.222222222224547.54211146DE
      412.222222222224547.5426045.92222222DE
      121027.77777777783648361431844.99787816DE
      2612.537.313432835833.54833910642.73855967DE
      5211.533.333333333334.54833709941.31408551DE
      156-1-2.127659574474752.533720143.42871417DE
      2606154052.525807940.54744064DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      KZIAKazia Therapeutics Ltd
      $ 1.28
      (91.56%)
      		101.07M
      LCFYLocafy Ltd
      $ 4.20
      (81.03%)
      		351.42k
      BDRXBiodexa Pharmaceuticals PLC
      $ 1.26
      (77.19%)
      		43.73M
      VLCNVolcon Inc
      $ 6.16
      (68.77%)
      		18.26M
      ISPCiSpecimen Inc
      $ 0.4801
      (67.93%)
      		18.98M
      CINGCingulate Inc
      $ 0.491
      (-24.23%)
      		670.07k
      CETUUCetus Capital Acquisition Corporation
      $ 7.58
      (-23.90%)
      		305
      IVPInspire Veterinary Partners Inc
      $ 5.84
      (-21.08%)
      		978.3k
      SLRXSalarius Pharmaceuticals Inc
      $ 2.23
      (-18.69%)
      		1.63M
      CLNNClene Inc
      $ 4.61
      (-17.97%)
      		31.61k
      KZIAKazia Therapeutics Ltd
      $ 1.27
      (90.06%)
      		101.08M
      RNLXRenalytix PLC
      $ 0.414
      (37.13%)
      		58.3M
      NVDANVIDIA Corporation
      $ 133.525
      (-1.03%)
      		55.17M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.19979
      (-5.22%)
      		54.73M
      BDRXBiodexa Pharmaceuticals PLC
      $ 1.26
      (77.19%)
      		43.73M

      Discussion

      View Full Feed
      TIMGZ TIMGZ 2 minutes ago
      HOW LOW WILL "BDRX" GO**** AVERAGING DOWN AND STILL HOLDING***MIGHT BOUNCE AND WOULDN'T BE SURPRISED IF IT TOUCHES $0.95
      BDRX
      Buddyboy20 Buddyboy20 2 minutes ago
      Misiu sent me a note and straightened me out. I apologize.
      CYDY
      Chartmaster Chartmaster 2 minutes ago
      Filled the gap open, support at 60, now we can go back up!
      SMCE
      ZRock ZRock 2 minutes ago
      keep undercutting the ask. grrrrrr
      KSCP
      JettaR JettaR 2 minutes ago
      Down 30% on 25k. Not so locked up. Nice dump before expert market hits.
      RGLG
      rack186 rack186 2 minutes ago
      Longs or fake longs ??
      ELTP
      wadegarret wadegarret 2 minutes ago
      updated

      PSIX 5000 shares

      GERN 43000 shares

      AAOI 14000 shares

      Cash negativde $1342
      GERN
      Real McCoy Real McCoy 2 minutes ago
      Clearly. You seem to want to talk about cosmetic attributes, which are not in dispute here at all, and I’d like to clear up the result of the liquidation, which have been meekly disputed. I also asked again for your thoughts on that dispute given your knowledge of the facts.
      jxyzobrien jxyzobrien 2 minutes ago
      not a happy family
      up move
      few things look good
      KILLAZILLA KILLAZILLA 2 minutes ago
      LOLOLOLOL....WHAT'S your DD SINCE you're NOW DOWN OVER 90% IN THIS POS SCAM!!!

      CHECK THE FINS. they(LYING GRIFTERS) ARE BROKE!!!
      WDLF
      glenn1919 glenn1919 2 minutes ago
      BIG......RCAT......STAF.......https://stockcharts.com/h-sc/ui?s=STAF&p=W&b=5&g=0&id=p84354014936
      https://stockcharts.com/h-sc/ui?s=BIG&p=W&b=5&g=0&id=p84354014936
      https://stockcharts.com/h-sc/ui?s=RCAT&p=W&b=5&g=0&id=p84354014936
      RCAT STAF
      Swammmie1040 Swammmie1040 3 minutes ago
      Got 2 milly this morning lol badgers were everywhere yesterday . Emotional trading will get ya all the time, good luck ….
      RONN
      ducci1 ducci1 3 minutes ago
      Ridin 560P .40---let see !
      SPY
      getmoreshares getmoreshares 3 minutes ago
      IMO this will see .50 before EOY- possibly much higher.
      NSAV
      Noghawbuck Noghawbuck 3 minutes ago
      🫏 🫏 what happened to Virginia Beech you forget about it was going to open in two weeks wonder why stock is below a penny you forget about your great shareholders holding the bag , your the best guys for the job !
      FUNN
      ducci1 ducci1 3 minutes ago
      May be time to go down & visit Da pivot at 5618 ?
      SPY
      Hawk05 Hawk05 3 minutes ago
      That’s just awesome! I’m praying for the best for both shareholders and Team BIEL but with the limited info hard to just continue with blind faith.
      BIEL
      sunspotter sunspotter 3 minutes ago
      “ Jeff should speak in general terms and explain what potential benefits going EM can have for a company.”

      There are literally zero benefits for the company or its shareholders in being on the “expert” market.

      It does however allow “management” to operate in the shadows
      RSPI
      Filterthenoise Filterthenoise 3 minutes ago
      Do it!!Spring this! $RNVA
      RNVA
      Mufaso Mufaso 3 minutes ago
      "Just over four million people are expected to use GLP-1s this year, according to Needham analyst Mike Matson, who used National Library of Medicine data to reach his estimate."

      This quote appeared in an article about Resmed (a maker of CPAP machines) being a buying opportunity:
      GLP
      tdbowieknife tdbowieknife 4 minutes ago
      FINRA will have an issue with the fraudulent disclosure statements.

      Rule 6490(d)(3) lays out the conditions under which an SEA Rule 10b-17 Action or Other Company-Related Action may be considered deficient and hence may not be processed. The rule outlines several factors that FINRA co
      GRLT
      stockinspector stockinspector 4 minutes ago
      Keep in mind that the loudest knuckle draggers here bought in around .02 cents a share thinking they would steal the show. They were impatient then and more so today. Now all they can do is complain and try to make others miss their opportunity to grow.
      WDLF
      Filterthenoise Filterthenoise 4 minutes ago
      EM is overblown. But I wouldn't be shocked if next week starts the fun 🤞
      RNVA
      nicehit nicehit 4 minutes ago
      It makes no sense that it's been like this for decades.
      Bashers on the OTC is rampant! But I have to say, at times, they are right.

      99% of these stocks are BS and nothing but paper movers.

      Hopefully, NSAV is on the right track this time. We will see in the nex
      NSAV

      Your Recent History

      LSE
      FLK
      Fletcher King
      Delayed Upgrade Clock